Scientific Programme Saturday, 17 March 2018 Patient, Family and Donor Day, Session 1 Coffee Break Patient, Family and Donor
Total Page:16
File Type:pdf, Size:1020Kb
44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme Saturday, 17 March 2018 Patient, Family Donor Day 09:25 - 10:30 Room 3A + Room 3B Patient, Family and Donor Day, Session 1 Chairs: Manuel Abecasis (Portugal) Welcome and Introduction 09:25 - 09:30 Manuel Abecasis (Portugal) What is a hematopoietic transplant? 09:30 - 09:50 Carlos Martins (Portugal) Choice of the stem cell product for transplant 09:50 - 10:10 Maria João Gutierrez (Portugal) Different progression phases of the transplant process 10:10 - 10:30 Filipa Moita (Portugal) 10:30 - 11:00 Room 3A + Room 3B Coffee Break Patient, Family Donor Day 11:00 - 12:30 Room 3A + Room 3B Patient, Family and Donor Day, Session 2 Chairs: Fernanda Soares (Portugal) Nursing care of the patient in the isolation unit 11:00 - 11:20 Elsa Oliveira (Portugal) Nursing care of the patient in the day unit 11:20 - 11:40 Cristina Santos (Portugal) The patient through the transplant process 11:40 - 12:10 Claudia Franco (Portugal) Eva Fraio (Portugal) Carlos Horta E Costa (Portugal) Cultural Moment - Guitar 12:10 - 12:30 João Lopes (Portugal) Francisco Palma (Portugal) Page 1 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme 12:30 - 13:30 Room 3A + Room 3B Lunch Break Patient, Family Donor Day 13:30 - 14:45 Room 3A + Room 3B Patient, Family and Donor Day, Session 3 Chairs: Helder Trindade (Portugal) Menachem Bitan (Israel) The role of the Portuguese donor registry (CEDACE) 13:30 - 13:45 Helder Trindade (Portugal) The role of the Spanish donor registry (REDMO) 13:45 - 14:00 Núria Marieges (Spain) The role of the Brazilian registry (REDOME) 14:00 - 14:15 Danielli Oliveira (Brazil) The role of the Worldwide Network for Blood & Marrow Transplantation 14:15 - 14:25 (WBMT) Anita Waldmann (Germany) On being a donor related 14:25 - 14:35 Nuno Lino (Portugal) On being a donor unrelated 14:35 - 14:45 João Soares (Portugal) How do I … ? 14:00 - 15:00 Room 5A HD1, How Do I...? Session 1 Select the best donor for my patient 14:00 - 14:30 Enric Carreras (Spain) Select the best haploidentical donor 14:30 - 15:00 Didier Blaise (France) How do I … ? 14:00 - 15:00 Room 5B HD2, How Do I...? Session 2 Diagnosis and management of toxoplasmosis and pneumocystis jiroveci 14:00 - 14:30 Rafael de la Cámara (Spain) Page 2 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme Diagnosis and management listeriosis and nocardiosis 14:30 - 15:00 Eolia Brissot (France) How do I … ? 14:00 - 15:00 Room 5C HD3, How Do I...? Session 3 Optimizing the outcomes of cord blood stem cells 14:00 - 14:30 Annalisa Ruggeri (France) CB versus other sources 14:30 - 15:00 Jaime Sanz (Spain) 14:45 - 15:15 Room 3A + Room 3B Coffee Break Statistics 15:00 - 18:00 Auditorium IV Stat1, Basic Statistics Basic Statistics 15:00 - 18:00 Richard Szydlo (United Kingdom) Antonella Santucci (Italy) Patient, Family Donor Day 15:15 - 16:40 Room 3A + Room 3B Patient, Family and Donor Day, Session 4 Chairs: Elsa Oliveira (Portugal) Social implications of the transplant 15:15 - 15:30 Mariana Guerreiro (Portugal) Teaching children in a transplant unit 15:30 - 15:45 Dina Ribeiro (Portugal) The patient associations' role - APCL 15:45 - 15:55 Michelle Búrigo (Portugal) The patient associations' role - Acreditar 15:55 - 16:05 Alexandra Correia (Portugal) The patient associations' role - LPCC 16:05 - 16:15 Rita Branco (Portugal) Page 3 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme The patient associations' role - ADL 16:15 - 16:25 Fátima Ferreira (Portugal) APLL activities focused on patients and caregivers 16:25 - 16:35 Isabel Barbosa (Portugal) Closing 16:35 - 16:40 How do I … ? 15:30 - 16:30 Room 5A HD4, How Do I...? Session 4 Managing severe aplastic anaemia 15:30 - 16:00 Lucrecia Yañez (Spain) Managing pure red cell aplasia 16:00 - 16:30 André Tichelli (Switzerland) How do I … ? 15:30 - 16:30 Room 5B HD5, How Do I... Session 5 - Optimizing stem cell mobilization - Supported by Sanofi Genzyme Chairs: Christian Chabannon (France) An interactive session to discuss means for : 15:30 - 16:30 Christian Chabannon (France) Improvement of autologous hematopoietic cell collection in 2018 Improvement of the logistics of stem cell mobilization and autologous collection in 2018 Improvement of patients quality of life during stem cell mobilization and collection in 2018 Improvement of autologous HCT outcome in 2018 Perspectives and conclusions for 2020 and beyond How do I … ? 15:30 - 16:30 Room 5C HD6, How do I... Session 6 - Approach differential diagnosis of post-transplant complications? - Supported by Jazz Pharmaceuticals Chairs: Nicolaus Kröger (Germany) Page 4 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme Welcome and introduction 15:30 - 15:35 Nicolaus Kröger (Germany) The challenge: Differential diagnosis of post-transplant complications 15:35 - 15:45 Nicolaus Kröger (Germany) Real-life solutions: Focus on severe VOD 15:45 - 16:05 David I. Marks (United Kingdom) Real-life solutions: Focus on GvHD 16:05 - 16:25 Rafael Duarte (Spain) Summary and close 16:25 - 16:30 Nicolaus Kröger (Germany) Page 5 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme Sunday, 18 March 2018 Non-Profit Symposium 08:30 - 10:00 Auditorium VI IS2, Multiple myeloma in 2018: the IFM global perspective - IFM Non-profit Symposium Chairs: Mohamad Mohty (France) Jean Luc Harousseau (France) Optimal induction in the transplant setting 08:30 - 08:45 Joan Bladé (Spain) Treatment of fit elderly myeloma 08:45 - 09:00 Thierry Facon (France) Role of double auto-transplant 09:00 - 09:15 Mohamad Mohty (France) Novel "new" drugs in the auto transplant setting 09:15 - 09:30 Paul G. Richardson (United States) Cost effectiveness of modern myeloma therapies 09:30 - 09:45 Jean Luc Harousseau (France) Round table discussion 09:45 - 10:00 Non-Profit Symposium 08:30 - 10:00 Auditorium VII IS3, Update in acute myeloid leukemia therapy - Supported by Sorbonne University, Paris, France Chairs: Arnon Nagler (Israel) Jordi Sierra (Spain) Therapy of young AML patients 08:30 - 08:50 Jordi Sierra (Spain) Personalizing therapy for AML: The MRC Approach 08:50 - 09:10 Nigel Russell (United Kingdom) Transplant in AML: balancing benefit versus risk 09:10 - 09:30 Jan Cornelissen (Netherlands) Does ATG increase relapse in Allo transplant for high risk AML? 09:30 - 09:50 Francesca Bonifazi (Italy) Discussion 09:50 - 10:00 Page 6 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme Non-Profit Symposium 08:30 - 10:00 Auditorium VIII IS4, Acute myeloid leukemia in 2018 - Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and Novartis, Non-profit Symposium Chairs: Marie-Thérèse Rubio (France) Jacques-Olivier Bay (France) Refining the Diagnosis and Prognostic Categorization of AML 08:30 - 09:00 Peter Paschka (Germany) Stem cell transplantation in AML in the era of targeted therapy 09:00 - 09:30 Nicolaus Kröger (Germany) CAR-T cells in AML: lessons from ALL 09:30 - 10:00 Nicolas Boissel (France) Nurses Group 08:30 - 10:00 Room 3A + Room 3B + Room 3C NG01, Nurses Educational Day Session 1 Chairs: Simone van der Linden (Netherlands) Elsa Oliveira (Portugal) Welcome and introduction 08:30 - 08:35 Simone van der Linden (Netherlands) Elsa Oliveira (Portugal) How do I provide essential care? 08:35 - 09:00 Caroline Bompoint (France) How can I support the patient with nutrition? 09:00 - 09:30 Katie Walker (United Kingdom) What conditioning do we use? 09:30 - 10:00 Anna Sureda (Spain) Statistics 09:00 - 12:00 Auditorium IV Stat2, Survival Analysis Survival Analysis 09:00 - 12:00 Antonella Santucci (Italy) Richard Szydlo (United Kingdom) Page 7 / 202 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 17 - 21 March 2018, Lisbon, Portugal Scientific Programme Industry Symposium 10:30 - 12:00 Auditorium VII IS5, A multidisciplinary approach to the management of CAR T-cell therapy - Novartis Industry Symposium Chairs: Gilles Salles (France) Welcome and introduction 10:30 - 10:35 Gilles Salles (France) Overview of CAR T-Cell Therapy 10:35 - 10:55 Gilles Salles (France) CAR T-Cell Therapy: The Clinician Perspective 10:55 - 11:15 Susana Rives (Spain) Apheresis: Overview and Challenges 11:15 - 11:30 Udo Holtick (Germany) Management of Patients in the Intensive Care Unit Following CAR T-Cell 11:30 - 11:45 Therapy Iolanda Jordan (Spain) Panel Discussion 11:45 - 11:55 Closing Remarks 11:55 - 12:00 Gilles Salles (France) Industry Symposium 10:30 - 12:00 Auditorium VIII IS6, Cytomegalovirus Prophylaxis - the New Paradigm - MSD Industry Symposium Chairs: Per Ljungman (Sweden) Welcome and Opening Remarks 10:30 - 10:35 Per Ljungman (Sweden) The Clinics: Cytomegalovirus Infection and Disease 10:35 - 10:55 Manuel Abecasis (Portugal) Early Anti-CMV Intervention 10:55 - 11:10 Per Ljungman (Sweden) The Economic Burden of CMV Infection and Disease 11:10 - 11:25 Corrado Girmenia (Italy) Letermovir – Study